The Role of Anthracyclines in Combination Chemotherapy for the Treatment of Follicular Lymphoma: Retrospective Study of the Intergruppo Italiano Linfomi on 761 Cases

References

• Rosenberg, S.A. (1979) "Current concepts in cancer: non-Hodgkin's lymphoma. Selection of treatment on the basis of histologic type", N. Engl. J. Med. 301, 924-928. Devesa, S.S. and Fears, T. (1992) "Non-Hodgkin's lymphoma time trends: United States and international data", Cancer Res. 52, 5465s. pj Horning, S.I. (1993) "Natural history of and therapy for the indolent non-Hodgkin's lymphoma", Semin. Oncol. 20, 75.
   Google Scholar
• Devesa, S.S. and Fears, T. (1992) "Non-Hodgkin�s lymphoma time trends: United States and international data", Cancer Res. 52, 5465s.
   PubMed Web of Science ®Google Scholar
• Horning, S.I. (1993) "Natural history of and therapy for the indolent non-Hodgkin�s lymphoma", Semin. Oncol. 20, 75.
   PubMed Web of Science ®Google Scholar
• Lister, TA., Cullen, M.H., Beard, ME., et al. (1978) "Comparison of combined and single agent chemotherapy in non-Hodgkin's lymphoma of favorable histological type", Br. Med. J. 1, 533.
   PubMed Web of Science ®Google Scholar
• Dana, B.W., Dahlberg, S., Nathwani, B.N., et al. (1993) "Long term follow-up of patients with low grade malignant lymphomas treated with doxorubicn-based chemotherapy or chemoimmunotherapy", J. Clin. Oncol. 11, 644.
   PubMed Web of Science ®Google Scholar
• Vose, J.M. (1998) "Current approaches to the management of non-Hodgkin's lymphoma", Semin. Oncol. 25, 483–491.
   PubMed Web of Science ®Google Scholar
• Horning, S.J. and Rosenberg, S.A. (1984) "The natural history of initially untreated low-grade non-Hodgkin's lymphomas", N. EngL J. Med. 311, 1471.
   PubMed Web of Science ®Google Scholar
• Solal-Celigny, P., Lepage, E., Brousse, N., et al. (1998) "Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the group d'etude des lymphomes folliculaires 86 trial", J. Clin. Oncol. 16(7), 2332–2338.
   Web of Science ®Google Scholar
• McLaughlin, P., Cabanillas, F., Hagemeister, F.B., et al. (1993) "CHOP-Bleo plus interferon for stage IV low-grade lymphoma", Ann. Oncol. 4, 205–211. JO] Freedman, A.S., Ritz, J., Neuberg, D., et al. (1991) "Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non Hodgkin's lymphoma", Blood 77, 2524.
   Google Scholar
• Freedman, A.S., Ritz, J., Neuberg, D., et al. (1991) "Autologous bone marrow transplantation in 69 patients with a history of lowgrade B-cell non Hodgkin�s lymphoma", Blood 77, 2524.
   PubMed Web of Science ®Google Scholar
• Rohatiner, A.Z.S., Johnson, P.W.M., Price, C.G.A., et al. (1994) "Myeloablative therapy with autologous bone marrow transplan-tation as consolidation therapy for recurrent follicular lymphoma", J. Clin. Oncol. 12, 117. P2] Bierman, P., Vose, J., Anderson, J., et al. (1996) "High dose with autologous hematopoietic rescue for follicular non-Hodgkin's lymphoma", Proc. Am. Soc. Clin. Oncol. 15, 317. P3] Colombat, P., Binet, C.H., Linassier, C., et al. (1992) "High-dose chemotherapy with autologous marrow transplantation in follicular lymphoma", Leuk. Lymphoma 7, 3.
   Google Scholar
• Bierman, P., Vose, J., Anderson, J., et al. (1996) "High dose with autologous hematopoietic rescue for follicular non-Hodgkin�s lymphoma", Proc. Am. Soc. Clin. Oncol. 15, 317.
   Web of Science ®Google Scholar
• Colombat, P., Binet, C.H., Linassier, C., et al. (1992) "High-dose chemotherapy with autologous marrow transplantation in follicular lymphoma", Leuk. Lymphoma 7, 3.
   PubMed Web of Science ®Google Scholar
• Federico, M., Vitolo, U., Zinzani, P.L., et al. (2000) "Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases", Blood 95(3), 783–789.
   PubMed Web of Science ®Google Scholar
• Gerard-Marchant, R., Hamlin, I., Lennert, K., et al. (1974) "Classification of non-Hodgkin's lymphomas", Lancet 2, 406.
   Web of Science ®Google Scholar
• Carbone, P.P., Kaplan, H.S., Musshoff, K., et al. (1971) "Report of the committee on Hodgkin's disease staging classification", Cancer Res. 31, 1860. P7] McKelvey, E.M., Gottlieb, J.A., Wilson, H.E., et al. (1976) "Hydroxydaunomycin combination chemotherapy in malignant lymphoma", Cancer 38, 1484–1493.
   Web of Science ®Google Scholar
• McKelvey, E.M., Gottlieb, J.A., Wilson, H.E., et al. (1976) "Hydroxydaunomycin combination chemotherapy in malignant lymphoma", Cancer 38, 1484�1493.
   Web of Science ®Google Scholar
• Bellesi, G., Rigacci, L., Longo, G., et al. (2000) "Treatment of large cell lymphoma with Fi2 regimen (doxorubicin, oncovin, cyclo-phosphamide, bleomycin and prednisone): a 20 years experience in a single institution", Oncol. Rep. 7(4), 891–896.
   Google Scholar
• Rodriguez, V., Cabanillas, F., Burgess, M.A., et al. (1977) "Combination chemotherapy (CHOP-Bleo) in advanced (non-Hodgkin's) malignant lymphoma", Blood 49, 326-333. poj Schipp, M., Klatt, M., Harrington, D., et al. (1985) "M-BACOD and m-BACOD in the treatment of unfavorable prognosis lymphoma: analysis of prognostic variables", Proc. Am. Soc. Oncol. 4, C–799.
   Google Scholar
• Schipp, M., Klatt, M., Harrington, D., et al. (1985) "M-BACOD and m-BACOD in the treatment of unfavorable prognosis lymphoma: analysis of prognostic variables", Proc. Am. Soc. Oncol. 4, C-799. [21] Klimo, P. and Connors, J.M. (1985) "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma", Ann. Int. Med. 102, 596�602.
   Google Scholar
• Klimo, P. and Connors, J.M. (1985) "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma", Ann. Int. Med. 102, 596–602.
   PubMed Web of Science ®Google Scholar
• Fisher, RI., De Vita, VT. Jr, Hubbard, S.M., et al. (1984) "Randomized trial of ProMace-MOPP vs. ProMACEcCytaBOM in previously untreated, advanced stage, diffuse aggressive lympho-mas", Proc. Am. Soc. Clin. Oncol. 3, C–945.
   Google Scholar
• Norton, L. and Simon, R. (1977) "Tumor size, sensitivity to therapy and design of treatment schedules", Cancer Treat. Rep. 61, 1307–1317.
   PubMedGoogle Scholar
• Nie, H.H., Hadlai, H., Jenkins, J.G., et al. (1979) SPSS (Statistical Package for the Social Sciences) (McGraw-Hill, New York, NY).
   Google Scholar
• Shipp, MA. and Harrington, D.P. (1993) "and the International non-Hodgkin's lymphoma. A predictive model for aggressive non-Hodgkin lymphoma", N. Engl. J. Med. 329, 987.
   PubMed Web of Science ®Google Scholar
• McLaughlin, P., Hagemeister, F.B., Romaguerra, J.E., Sarris, AR, Pate, 0., Younes, A., Swan, F., Keating, M. and Cabanillas, F. (1996) "Fludarabine, mitoxantrone and dexamethasone: an effective new regimen for indolent lymphoma", J. Clin. Oncol. 14(4), 1262–1268.
   PubMed Web of Science ®Google Scholar
• Czuczman, M.S., Fallon, A., Mohr, A., Stewart, C., Bernstein, Z.P., McCarthy, P., Skipper, M., Brown, K., Miller, K., Wentling, D., et al. (2002) "Rituximab in combination with CHOP or fludarabine in low-grade lymphoma", Semin. Oncol. 29(1), 36–40, Suppl. 2.
   Google Scholar
• Ezdinli, E.Z., Anderson, J.R., Melvin, F., et al. (1985) "Moderate vs. aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma", J. Clin. Oncol. 3(6), 769–775.
   Web of Science ®Google Scholar
• Dana, B.W., Dahlberg, S., Nathwani, B.N., et al. (1993) "Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy", J. Clin. Oncol. 11(4), 644-651. poj Kimby, E., Bjorkholm, M., Gahrton, G., et al. (1994) "Chlor-ambucil/Prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the lymphoma group of central Sweden", Ann. Oncol. 5(2), 67–71.
   Google Scholar
• Kimby, E., Bjorkholm, M., Gahrton, G., et al. (1994) "Chlorambucil/ Prednisone vs. CHOP in symptomatic low-grade non- Hodgkin�s lymphomas: a randomized trial from the lymphoma group of central Sweden", Ann. Oncol. 5(2), 67�71.
   Google Scholar
• Lepage, E., Sebban, C., Gisselbrecht, C., et al. (1990) "Treatment of low-grade non-Hodgkin's lymphomas: assessment of doxorubicin in a controlled trial", Hematol. Oncol. 8(1), 31–39.
   Google Scholar
• Young, R.C., Longo, DL, Glatstein, E., et al. (1988) "The treatment of indolent lymphomas: watchful waiting vs. aggressive combined modality treatment", Semin. Hematol. 25, 11–16.
   PubMed Web of Science ®Google Scholar
• Peterson, B.A., Frizzera, J.R., Anderson, J.R., et al. (1985) "Response of low-grade lymphoma to cyclophosphamide or cyclophosphamide, adriamycin, vincristine, prednisone and bleo-mycin", Proc. Am. Soc. Clin. Oncol. 4, 211a.
   Google Scholar
• Dana, B.W., Dahlberg, S., Nathwani, B.N., et al. (1994) "Intensive conventional-dose chemotherapy for stage IV low-grade lym-phoma: high remission rates and reversion to negative of peripheral blood bc1-2 rearrangement", Ann. Oncol. 5(2), S73 �"S77.
   Google Scholar
• Czuczman, MS., Grillo-Lopez, A.J., White, C.A., et al. (1999) "Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy", J. Clin. Oncol. 17(1), 268–276.
   PubMed Web of Science ®Google Scholar
• Gribben, J., Neuberg, D., Freedman, A., et al. (1993) "Detection by polymerase chain reaction of residual cells with the bc1-2 traslocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma", Blood 81, 3449–3457.
   PubMed Web of Science ®Google Scholar